Carolina Business Review: Panel Interview with BioAgilytix CEO Jim Datin

BioAgilytix in the News

Outsourcing-Pharma.com logo
23 November, 2017

ATCC Adds Novel In Vitro Model to Expanding Portfolio

ATCC has released an in vitro model system for a key mechanism of invasion and metastasis in lung cancer as the company continues its efforts to provide drug discovery and development services.

Read More

TBJ logo
9 March, 2017

Durham’s BioAgilytix Heading into Expansion Mode

BioAgilytix is beefing up in Durham. The contact research organization is expanding its existing 29,000-square-foot space to roughly 50,000 square feet at 2300 Englert Drive and is planning to hire roughly 60 employees by the end of this year, according to President and CEO Jim Datin.

Read More

GEN Genetic Engineering and Biotechnology News logo
1 January, 2017

Cell-Based Assays Keep Biosimilars on Track

The cell-based assay has become a mainstay of drug development, addressing new concerns raised by the advent of biologics. Whereas small molecule drugs may escape detection by the immune system, larger protein therapeutics, such as monoclonal antibodies, are apt to trigger immunogenic alarms.

Read More

Outsourcing-Pharma.com logo
23 October, 2016

CRO BioAgilytix and ATCC Sign Strategic Partnership

ATTC has signed a strategic agreement with the contract research organization (CRO) BioAgilytix as part of its ongoing initiative to provide CRO services. The agreement will span multi-year and involved a co-marketing arrangement across ATCC's complementary areas of cell biology services.

Read More

TBJ logo
22 February, 2016

How Durham’s BioAgilytix Courted a German Bioanalytical Lab

BioAgilytix, a Durham-based contract research organization, closed on an acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory with expertise in large molecule bioanalysis, particularly in the area of immunogenicity.

Read More

Bioanalysis Zone logo
15 December, 2015

Building Partnerships with Other CROs

By nature, the idea of CRO partnerships is attractive to Executives and Business Development Teams because such alignments equip their CRO with a more comprehensive, and thus competitive list of service offerings. This article is my attempt to share the dos, and most importantly, the don’ts in establishing mutually beneficial alliances with other CROs.

Read More

Bioanalysis Zone logo
23 September, 2015

How to Win Client Trust as a CRO

The act of building trust with your pharmaceutical and biotech clients is similar to how trust is built between friends – both require time, mutual respect and appreciation. This article discuesses how numerous teams within the CRO and sponsor organization work together to establish trust, and ultimately a fruitful partnership.

Read More

Bioanalysis Zone logo
28 August, 2015

How to Set up a Successful CRO by Surrounding Yourself with the Right Team Members

It is very important for executives of CRO companies to recognize that the most critical factor in making a CRO successful is the people that you hire. A CRO can have the latest and greatest platform instruments and technology, but these novel tools would be a wasted investment without quality scientists.

Read More

TBJ logo
17 August, 2015

Durham’s BioAgilytix Continues Growth Spurt; Plans to Add More Jobs

BioAgilytix doubled its customer base from 2013 to 2014 and already doubled again by August of this year. The company has 60 percent organic year-over-year growth and Datin expects to acquire a company in Europe by the end of the year. Last year, it worked with 12 of the 25 largest pharmaceutical and biotechnology companies, a figure that has increased to 19 this year.

Read More

Bioanalysis Zone logo
1 July, 2015

Starting a CRO on Personal Credit

Bioanalysis Zone Regardless of the size of the CRO, the quality of the work that I received was most dependent on the specific team managing and working on my projects.…

Read More